Center for Medicine in the Public Interest Challenges Accuracy of 60 Minutes Cancer Story
This week, the Center for Medicine in the Public Interest issued a press release criticizing …
Tony Coelho: A Patient Advocate's Perspective on Paying for Value
Yesterday, Health Affairs published an op-ed by Tony Coelho, Former Member of the U.S. House …
Answering the Call for Cures in Michigan
This week, the Kalamazoo Gazette published an op-ed on how we can accelerate the discovery, …
USDA Illuminates the Economic Benefits of Moving Toward a Biobased Economy
“A bioeconomy is one based on the use of research and innovation in the biological sciences to …
2014 BIO Investor Forum Fireside Chat with Nick Leschly and Chris Collins
Nick Leschly has served as bluebird bio’s president and chief executive officer since September 2010. …
Blurred Lines: Investors Explain Their Re-Thinking of Traditional Private-Only or Public-Only Invest...
The recent expansion and acceleration of the biotech stock market has seen a new willingness …